Histogenics (HSGX) Stock: Continues Soaring On Partnership News!

Histogenix HSGX Stock News

Histogenics Corp (NASDAQ: HSGX) is having an incredibly strong start to the trading session this morning, following up on the incredible day that the stock had in the market yesterday. The gains came after the company announced a new partnership. Today, we’ll talk about: The partnership; what we’re seeing from HSGX stock as a result; … Read more

Histogenics (HSGX) Stock: Flying On Acquisition News

Histogenix HSGX Stock News

Histogenics Corp (NASDAQ: HSGX) is having an incredible start to the trading session, trading with gains well over 100% in the pre-market. The gains follow an announcement that the company will merge with Ocugen, leaving Ocugen as the majority owners of HSGX outstanding common stock. Today, we’ll talk about: The merger; what we’re seeing from … Read more

Histogenics (HSGX) Stock: Don’t Get Too Excited

Histogenics HSGX Stock News

Histogenics Corp (NASDAQ: HSGX) is flying early on in the market today. However, the company hasn’t issued any news that would be a clear cause for the run. Moreover, after digging through financial media and message boards, there’s no catalyst to pin down. Nonetheless, there’s a lot to talk about, and it is strongly suggested … Read more

Histogenics (HSGX) Stock: Tumbling On Offering News

xHistogenics Corp (NASDAQ: HSGX) is having an overwehlmingly rough start to the trading session this morning, and for good reason. The company announced the pricing of a public offering, upsetting investors and sending the stock tumbling down. Today, we’ll talk about: The offering; what we’re seeing from HSGX as a result; and what we’ll be … Read more

Histogenics (HSGX) Stock: Here’s Why It’s Up

Histogenics CorpĀ (NASDAQ: HSGX) is having an incredibly strong start to the trading session this morning. However, if you go digging for news, you’re not going to find anything recent. That doesn’t mean that there’s no fundamental reason for today’s gains. Below, we’ll talk about: Why HSGX is headed up; what we’re seeing from the stock; … Read more

Histogenics (HSGX) Stock: Falling Hard On Failed Clinical Trial

Histogenics Corp (NASDAQ: HSGX) is having an overwhelmingly rough start to the trading session this morning, and for good reason. The comapny announced clinical data that didn’t quite meet up with expectations. Of course, the failed trial proved to be a cause for concern for investors who are sending the stock spiralind down in the … Read more